| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| O833148 | MACKLIN | 奥美沙坦酯 | 98% | 80元/250mg; 270元/1g; 374元/5g; | 咨询 |
|
| O798265 | MACKLIN | 奥美沙坦酯 | 10mM in DMSO | 516元/1ml; | 咨询 |
|
| O0510 | TCI | Olmesartan Medoxomil | >98.0%(T)(HPLC) | 585元/1G; 2035元/5G; | 咨询 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C29H30N6O6 = 558.60 | | 外观与形状(20℃) | 固体 | | 储存温度 | <0℃ | | 应避免的情况 | 加热 | | 包装和容器 | 1G-带有塑料内管的玻璃瓶 (查看图片) | | Reaxys-RN | 7506931 | | PubChem物质ID | 354335790 | | Merck Index (14) | 6839 | | MDL编号 | MFCD00944911 |
技术规格 | Appearance | White to Light yellow powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % |
物性(参考值) | 熔点 | 180 ℃(dec.) | | 水溶性 | 不溶 | | 溶解性(微溶于) | 丙酮,甲醇 | | 溶解度(极微溶) | 乙醇 |
安全信息 | 图形或危害标志 |  | | 信号词 | 警告 | | 危险性说明 | H361 : 怀疑对生育能力或胎儿造成伤害。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P202 : 在阅读并明了所有安全措施前切勿搬动。 P201 : 使用前取得专用说明。 P280 : 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P308 + P313 : 如接触到或有疑虑:求医/就诊。 P405 : 存放处须加锁。
|
相关法规 |
| C46250 | Alfa Aesar | Olmesartan Medoxomil | | 1045元/1g; 3609元/5g; | 咨询 |
基本信息 Ref# 46250 分子式 C29H30N6O6 分子量 437.52 |
| Y0001405 | | Olmesartan Medoxomil | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C29H30N6O6 | | 分子量 | 558.59 | | MDL编号 | MFCD00944911 | | PubChem化学物质编号 | 329831406 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CCCC1=NC(C(O)(C)C)=C(C(OCC2=C(C)OC(O2)=O)=O)N1CC(C=C3)=CC=C3C4=CC=CC=C4C5=NN=NN5 | | InChI | 1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34) | | InChI key | UQGKUQLKSCSZGY-UHFFFAOYSA-N | | Gene Information | human ... AGTR1(185) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 + H312 + H332 | | 预防措施声明 | P261 - P264 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 | | 危险分类 | Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0001424 | | Olmesartan medoxomil for system suitability | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C29H30N6O6 | | 分子量 | 558.59 | | MDL编号 | MFCD00944911 | | PubChem化学物质编号 | 329831420 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CCCC1=NC(C(O)(C)C)=C(C(OCC2=C(C)OC(O2)=O)=O)N1CC(C=C3)=CC=C3C4=CC=CC=C4C5=NN=NN5 | | InChI | 1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34) | | InChI key | UQGKUQLKSCSZGY-UHFFFAOYSA-N | | Gene Information | human ... AGTR1(185) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 + H312 + H332 | | 预防措施声明 | P261 - P264 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 | | 危险分类 | Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| PHR1851 | Supelco | Olmesartan Medoxomil | Pharmaceutical Secondary Standard; Certified Reference Material | 2252.27元/200 MG; | 咨询 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAC2529 in the Documents slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C29H30N6O6 | | 分子量 | 558.59 | | MDL编号 | MFCD00944911 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | 包装 | pkg of 200 mg | | application(s) | pharmaceutical | | 格式 | neat | | 药典可追溯性 | traceable to BP 1173 traceable to PhEur Y0001405 traceable to USP 1478367 | | 储存温度 | -10 to -25℃ | | SMILES string | CCCC1=NC(C(O)(C)C)=C(C(OCC2=C(C)OC(O2)=O)=O)N1CC(C=C3)=CC=C3C4=CC=CC=C4C5=NN=NN5 | | InChI | 1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34) | | InChI key | UQGKUQLKSCSZGY-UHFFFAOYSA-N | | Gene Information | human ... AGTR1(185) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 + H312 + H332 | | 预防措施声明 | P261 - P264 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 | | 危险分类 | Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP1173 | | Olmesartan Medoxomil | British Pharmacopoeia (BP) Reference Standard | 2144.18元/100 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C29H30N6O6 | | 分子量 | 558.59 | | MDL编号 | MFCD00944911 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CCCC1=NC(C(O)(C)C)=C(C(OCC2=C(C)OC(O2)=O)=O)N1CC(C=C3)=CC=C3C4=CC=CC=C4C5=NN=NN5 | | InChI | 1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34) | | InChI key | UQGKUQLKSCSZGY-UHFFFAOYSA-N | | Gene Information | human ... AGTR1(185) |
安全信息 | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| SML1391 | Sigma-Aldrich | Olmesartan Medoxomil | ≥98% (HPLC) | 1117.23元/50 MG; 4498.97元/250 MG; | 咨询 |
产品说明 包装 50, 250 mg in glass bottle 生化/生理作用 Olmesartan medoxomil is a selective Angiotensin II Type I receptor blocker and antihypertensive drug. Olmesartan medoxomil is converted enzymatically to the active form olmesartan. Olmesartan medoxomil is considered as an antihypertensive agent. It is an angiotensin 2 type 1 antagonist receptor. It is a prodrug which releases the parent compound olmesartan after ingestion. Olmesartan is ejected via kidney and liver. In humans, olmesartan protects renal and cardiovascular systems. This drug may be used in the treatment of hypertension. 基本信息 | 经验(实验)分子式 | C29H30N6O6 | | 分子量 | 558.59 | | MDL编号 | MFCD00944911 | | PubChem化学物质编号 | 329825839 | | NACRES | NA.77 |
产品性质 | 质量水平 | 100 | | 测定 | ≥98% (HPLC) | | 形式 | powder | | 颜色 | white to beige | | 溶解性 | DMSO: 10 mg/mL, clear | | 储存温度 | 2-8℃ | | SMILES string | CCCC1=NC(C(O)(C)C)=C(C(OCC2=C(C)OC(O2)=O)=O)N1CC(C=C3)=CC=C3C4=CC=CC=C4C5=NN=NN5 | | InChI | 1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34) | | InChI key | UQGKUQLKSCSZGY-UHFFFAOYSA-N | | Gene Information | human ... AGTR1(185) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 + H312 + H332 | | 预防措施声明 | P261 - P264 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 | | 危险分类 | Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1478367 | USP | Olmesartan Medoxomil | United States Pharmacopeia (USP) Reference Standard | 6792.19元/100 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C29H30N6O6 | | 分子量 | 558.59 | | MDL编号 | MFCD00944911 | | PubChem化学物质编号 | 329750607 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | −20℃ | | SMILES string | CCCC1=NC(C(O)(C)C)=C(C(OCC2=C(C)OC(O2)=O)=O)N1CC(C=C3)=CC=C3C4=CC=CC=C4C5=NN=NN5 | | InChI | 1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34) | | InChI key | UQGKUQLKSCSZGY-UHFFFAOYSA-N | | Gene Information | human ... AGTR1(185) |
安全信息 | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|